Investor Relations

5-Years Results

Medical Net

Consolidated Income Statements

(unit: 1,000yen)
FY2018 FY2019 FY2020 FY2021 FY2022
Net sales1,498,1761,964,5242,570,1822,904,6023,745,765
Operating income152,747176,078106,378331,269449,877
Ordinary income154,846182,813103,972336,286454,334
Profit attributable to shareholders of parent88,141102,24679,346129,671384,857

Blance Sheets

(unit: 1,000yen)
FY2018 FY2019 FY2020 FY2021 FY2022
Current assets1,650,1621,596,3141,205,4631,505,1862,077,986
Non-current assets234,770454,820531,174602,0491,076,455
Total assets1,884,9322,051,1341,736,6382,107,2353,154,441
Current liabilities332,321340,644677,148722,5411,300,468
Non-current liabilities-68,16753,030124,434116,440
Capital stock286,034286,034286,034286,034286,034
Total shareholders' eruity1,543,2981,634,953996,0921,240,5291,696,609
Total net assets1,552,6111,642,3221,006,4591,260,2591,737,533

Cash Flows Statements

(unit: 1,000yen)
FY2018 FY2019 FY2020 FY2021 FY2022
Cash flow from operating activities116,441△68,80178,294391,866342,551
Cash flow from investing activities△42,52361,939△14,604△87,989△355,110
Cash flow from financing activities△49,551△10,695△497,401△34,032282,234
Cash and cash equivalents at the end of period1,172,8421,154,973595,895868,6611,128,788

Manegement Index

FY2018 FY2019 FY2020 FY2021 FY2022
Equity capital raito (%)82.079.757.459.054.1
ROE (%)5.86.46.011.626.1